{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:36:39Z","timestamp":1787063799814,"version":"build-2736575974"},"reference-count":20,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2011,4,19]],"date-time":"2011-04-19T00:00:00Z","timestamp":1303171200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J of Obstet and Gynaecol"],"published-print":{"date-parts":[[2011,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:bold>Aims:\u2002<\/jats:bold>\n                    Increasing evidence supports the participation of metabolic syndrome and insulin resistance in the pathogenesis of pre\u2010eclampsia. Copeptin is co\u2010synthesized with vasopressin and is a new and promising novel marker of metabolic syndrome and insulin resistance. Our aim was to investigate copeptin levels in normotensive pregnant, mild and severe pre\u2010eclamptic women.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Materials and Methods:\u2002<\/jats:bold>\n                    We included 96 pregnant women who received antenatal and obstetric care at the perinatology clinic of our hospital. They were divided into three groups: women with normal ongoing pregnancy (\n                    <jats:italic>n<\/jats:italic>\n                    \u2003=\u200332), those with mild pre\u2010eclampsia (\n                    <jats:italic>n<\/jats:italic>\n                    \u2003=\u200332) and those with severe pre\u2010eclampsia (\n                    <jats:italic>n<\/jats:italic>\n                    \u2003=\u200332). Doppler velocimetry measurements of the uterine and umbilical arteries were performed for each patient. Plasma levels of copeptin were quantified with enzyme\u2010linked immunosorbent assay.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:\u2002<\/jats:bold>\n                    Plasma levels of copeptin were 0.31\u2003\u00b1\u20030.09\u2003ng\/mL in the normotensive pregnant group, 0.62\u2003\u00b1\u20030.16\u2003ng\/mL in the mild pre\u2010eclamptic group and 0.85\u2003\u00b1\u20030.18\u2003ng\/mL in the severe pre\u2010eclamptic group (\n                    <jats:italic>P<\/jats:italic>\n                    \u2003&lt;\u20030.001). Copeptin levels in pre\u2010eclamptic patients with abnormal Doppler velocimetry were significantly higher than in those with normal Doppler velocimetry.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusions:\u2002<\/jats:bold>\n                    These results suggest that increased maternal levels of copeptin may be involved in the pathogenesis of pre\u2010eclampsia and it may be useful in the assessment of the severity of the disease.\n                  <\/jats:p>","DOI":"10.1111\/j.1447-0756.2010.01498.x","type":"journal-article","created":{"date-parts":[[2011,4,19]],"date-time":"2011-04-19T00:28:32Z","timestamp":1303172912000},"page":"1198-1202","source":"Crossref","is-referenced-by-count":54,"title":["Circulating levels of copeptin, a novel biomarker in pre\u2010eclampsia"],"prefix":"10.1111","volume":"37","author":[{"given":"Ebru","family":"Zulfikaroglu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mine","family":"Islimye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esra Aysin","family":"Tonguc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"Payasli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferruh","family":"Isman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Turgut","family":"Var","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuri","family":"Danisman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,4,19]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000188408.49896.c5"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1080\/10641950600912976"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-006-0264-x"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2004.01.038"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006254-199804000-00021"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-2278"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2007.11.001"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-0232"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1186\/cc6799"},{"key":"e_1_2_5_11_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0002-9378(00)99785-0","volume":"183","author":"Report of National High Blood Pressure Education Program Working Group on high blood pressure in pregnancy","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0029-7844(00)00946-7"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1515\/jpme.1990.18.3.165"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2008.49.1.138"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1210\/en.138.6.2354"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2007.03147.x"},{"key":"e_1_2_5_17_2","first-page":"1","article-title":"Increased visfatin and leptin in pregnancies complicated by preeclampsia","volume":"1","author":"Adali E","year":"2009","journal-title":"J Matern Fetal Neonatal Med"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e318195b223"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2006.11.002"},{"key":"e_1_2_5_20_2","doi-asserted-by":"crossref","unstructured":"Mazaki\u2010ToviS RomeroR KusanovicJRet\u2003al.Maternal visfatin concentration in normal pregnancy.200937:206\u2013217.","DOI":"10.1515\/JPM.2009.054"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1080\/14767050902794642"}],"container-title":["Journal of Obstetrics and Gynaecology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1447-0756.2010.01498.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1447-0756.2010.01498.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T17:04:21Z","timestamp":1697303061000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1111\/j.1447-0756.2010.01498.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,19]]},"references-count":20,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["10.1111\/j.1447-0756.2010.01498.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1447-0756.2010.01498.x","archive":["Portico"],"relation":{},"ISSN":["1341-8076","1447-0756"],"issn-type":[{"value":"1341-8076","type":"print"},{"value":"1447-0756","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,19]]}}}